Subhani Okarvi

Dr. Subhani Okarvi is Senior Scientist in radiopharmaceuticals research specialising in developing innovative radiopharmaceuticals for potential clinical translation. He is experienced in solid-phase peptide synthesis, new PET and SPECT radiopharmaceuticals development, and bench-to-bedside translation. Currently, he is focused on advancing diagnostic nuclear imaging solutions and supporting clinical research initiatives.

Radiopharmaceutical research and development

Synthesis of clinically relevant peptides and biomolecules

Preclinical evaluation of peptides and biomolecules

Radiolabelling of biomolecules with diagnostic and therapeutic radionuclides

PET and SPECT imaging of small animals

Quality control of radiopharmaceuticals

Mass spectrometric characterisation of peptides and biomolecules

GLP compliance

Dr. Okarvi has over 25 years of experience in nuclear medicine research and radiopharmaceutical development. He previously worked on the development of SPECT radiopharmaceuticals at the University of Alberta, Canada. He holds a PhD in Radiopharmaceutical Sciences/Nuclear Medicine and has successfully led multiple research and clinical support projects.